Clear 618 Results Filter Filter Results Type: Press Release $100 Million Invested in Clinical Research for Impella Type: Press Release Abiomed Announces Q3 FY 2019 Record Revenue of $201 Million up 30% over Prior Year Type: Press Release Abiomed Third Quarter Fiscal 2019 Earnings and Conference Call Notification Type: Press Release Abiomed Announces Preliminary Q3 FY 2019 Revenue of $201 Million Up 30% Over Prior Year and Increases Full Year Guidance Type: Press Release Abiomed to Present at the 37th Annual JP Morgan Healthcare Conference Type: Press Release FDA Safety Study of Unloading the Left Ventricle for 30 Minutes Prior to Reperfusion in Heart Attack Patients is Safe and Feasible Type: Press Release Abiomed to Present at the Stephens 2018 Investment Conference in New York NY Type: Press Release Abiomed Announces Q2 FY 2019 Record Revenue of $182 Million up 37% Over Prior Year Type: Press Release Abiomed Second Quarter Fiscal 2019 Earnings and Conference Call Notification Type: Press Release Data Presented at TCT 2018 Shows Use of Impella and Best Practices Increases Cardiogenic Shock Survival … 30 31 32 33 …
